Literature DB >> 16966666

Natriuretic peptides in the diagnosis and management of heart failure.

G Michael Felker1, John W Petersen, Daniel B Mark.   

Abstract

The natriuretic peptides are a family of related hormones that play a crucial role in cardiovascular homeostasis. They have recently emerged as potentially important clinical markers in heart failure. Recent data have suggested an important role for these markers in establishing the diagnosis of heart failure in patients with unexplained dyspnea in both acute care and ambulatory settings. Other clinical uses of the natriuretic peptides, such as screening for asymptomatic ventricular dysfunction, establishing prognosis or guiding titration of drug therapy, are under investigation but have not yet sufficiently been validated for widespread clinical use.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16966666      PMCID: PMC1559415          DOI: 10.1503/cmaj.060236

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  43 in total

1.  Should B-type natriuretic peptide be measured routinely to guide the diagnosis and management of chronic heart failure?

Authors:  Milton Packer
Journal:  Circulation       Date:  2003-12-16       Impact factor: 29.690

2.  Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT).

Authors:  Inder S Anand; Lloyd D Fisher; Yann-Tong Chiang; Roberto Latini; Serge Masson; Aldo P Maggioni; Robert D Glazer; Gianni Tognoni; Jay N Cohn
Journal:  Circulation       Date:  2003-03-11       Impact factor: 29.690

3.  Brain natriuretic peptide and n-terminal brain natriuretic peptide in the diagnosis of heart failure in patients with acute shortness of breath.

Authors:  John G Lainchbury; Elizabeth Campbell; Christopher M Frampton; Timothy G Yandle; M Gary Nicholls; A Mark Richards
Journal:  J Am Coll Cardiol       Date:  2003-08-20       Impact factor: 24.094

4.  Plasma B-type natriuretic peptide levels in ambulatory patients with established chronic symptomatic systolic heart failure.

Authors:  W H Wilson Tang; John P Girod; Michael J Lee; Randall C Starling; James B Young; Frederick Van Lente; Gary S Francis
Journal:  Circulation       Date:  2003-12-08       Impact factor: 29.690

5.  Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure.

Authors:  Damien Logeart; Gabriel Thabut; Patrick Jourdain; Christophe Chavelas; Pascale Beyne; Florence Beauvais; Erik Bouvier; Alain Cohen Solal
Journal:  J Am Coll Cardiol       Date:  2004-02-18       Impact factor: 24.094

Review 6.  Prevention and management of chronic heart failure in management of asymptomatic patients.

Authors:  Maria Frigerio; Fabrizio Oliva; Fabio M Turazza; Robert O Bonow
Journal:  Am J Cardiol       Date:  2003-05-08       Impact factor: 2.778

7.  Impact of obesity on plasma natriuretic peptide levels.

Authors:  Thomas J Wang; Martin G Larson; Daniel Levy; Emelia J Benjamin; Eric P Leip; Peter W F Wilson; Ramachandran S Vasan
Journal:  Circulation       Date:  2004-02-10       Impact factor: 29.690

8.  Plasma brain natriuretic peptide to detect preclinical ventricular systolic or diastolic dysfunction: a community-based study.

Authors:  Margaret M Redfield; Richard J Rodeheffer; Steven J Jacobsen; Douglas W Mahoney; Kent R Bailey; John C Burnett
Journal:  Circulation       Date:  2004-06-07       Impact factor: 29.690

9.  Obesity and suppressed B-type natriuretic peptide levels in heart failure.

Authors:  Mandeep R Mehra; Patricia A Uber; Myung H Park; Robert L Scott; Hector O Ventura; Bobbett C Harris; Edward D Frohlich
Journal:  J Am Coll Cardiol       Date:  2004-05-05       Impact factor: 24.094

10.  Plasma amino-terminal pro-brain natriuretic peptide and accuracy of heart-failure diagnosis in primary care: a randomized, controlled trial.

Authors:  Susan P Wright; Robert N Doughty; Ann Pearl; Greg D Gamble; Gillian A Whalley; Helen J Walsh; Gary Gordon; Warwick Bagg; Helen Oxenham; Tim Yandle; Mark Richards; Norman Sharpe
Journal:  J Am Coll Cardiol       Date:  2003-11-19       Impact factor: 24.094

View more
  35 in total

Review 1.  Obesity and natriuretic peptides, BNP and NT-proBNP: mechanisms and diagnostic implications for heart failure.

Authors:  Chaitanya Madamanchi; Hassan Alhosaini; Arihiro Sumida; Marschall S Runge
Journal:  Int J Cardiol       Date:  2014-08-09       Impact factor: 4.164

2.  Identifying biomarker patterns and predictors of inflammation and myocardial stress.

Authors:  Ruth M Masterson Creber; Christopher S Lee; Kenneth Margulies; Barbara Riegel
Journal:  J Card Fail       Date:  2015-02-26       Impact factor: 5.712

3.  Natriuretic peptides and heart failure.

Authors:  Craig S McLachlan; Haidong Yu; Peter Mossop
Journal:  CMAJ       Date:  2007-02-27       Impact factor: 8.262

4.  Microarray methods for protein biomarker detection.

Authors:  Hye Jin Lee; Alastair W Wark; Robert M Corn
Journal:  Analyst       Date:  2008-06-05       Impact factor: 4.616

Review 5.  Guanylyl cyclase / atrial natriuretic peptide receptor-A: role in the pathophysiology of cardiovascular regulation.

Authors:  Kailash N Pandey
Journal:  Can J Physiol Pharmacol       Date:  2011-08-04       Impact factor: 2.273

Review 6.  The functional genomics of guanylyl cyclase/natriuretic peptide receptor-A: perspectives and paradigms.

Authors:  Kailash N Pandey
Journal:  FEBS J       Date:  2011-04-07       Impact factor: 5.542

7.  Apelin attenuates hyperoxic lung and heart injury in neonatal rats.

Authors:  Yvonne P de Visser; Frans J Walther; El Houari Laghmani; Arnoud van der Laarse; Gerry T M Wagenaar
Journal:  Am J Respir Crit Care Med       Date:  2010-07-09       Impact factor: 21.405

8.  The prognostic value of N-terminal pro-B-type natriuretic peptide for death and cardiovascular events in healthy normal and stage A/B heart failure subjects.

Authors:  Paul M McKie; Alessandro Cataliotti; Brian D Lahr; Fernando L Martin; Margaret M Redfield; Kent R Bailey; Richard J Rodeheffer; John C Burnett
Journal:  J Am Coll Cardiol       Date:  2010-05-11       Impact factor: 24.094

9.  N-terminal pro-brain natriuretic peptide and exercise capacity in chronic heart failure: data from the Heart Failure and a Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) study.

Authors:  G Michael Felker; David Whellan; William E Kraus; Robert Clare; Faiez Zannad; Mark Donahue; Kirkwood Adams; Robert McKelvie; Ileana L Piña; Christopher M O'Connor
Journal:  Am Heart J       Date:  2009-10       Impact factor: 4.749

10.  Sensitive detection of protein and miRNA cancer biomarkers using silicon-based photonic crystals and a resonance coupling laser scanning platform.

Authors:  Sherine George; Vikram Chaudhery; Meng Lu; Miki Takagi; Nabil Amro; Anusha Pokhriyal; Yafang Tan; Placid Ferreira; Brian T Cunningham
Journal:  Lab Chip       Date:  2013-08-20       Impact factor: 6.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.